Skip to main content

Sentinel surveillance for influenza A viruses in Lahore District Pakistan in flu season 2015–2016

Abstract

Background

Influenza A virus (IAV) remains an important global public health threat with limited epidemiological information available from low-and-middle-income countries. The major objective of this study was to describe the proportions, temporal and spatial distribution, and demographic and clinical characteristics of IAV positive patients with influenza like illness (ILI) and severe acute respiratory illness (SARI) in Lahore, Pakistan.

Methods

Prospective surveillance was established in a sentinel hospital from October 2015 to May 2016. All eligible outpatients and inpatients with ILI or SARI were enrolled in the study. Nasal and/or throat swabs were collected along with clinico-epidemiological data. Samples were tested by real-time RT-PCR (rRT-PCR) to identify IAV and subtype. The descriptive analysis of data was done in R software.

Results

Out of 311 enrolled patients, 284 (91.3%) were ILI and 27 (8.7%) were SARI cases. A distinct peak of ILI and SARI activity was observed in February. Fifty individuals (16%) were positive for IAV with peak positivity observed in December. Of 50 IAV, 15 were seasonal H3N2, 14 were H1N1pdm09 and 21 were unable to be typed. The majority of IAV positive cases (98%) presented with current or history of fever, 88% reported cough and 82% reported sore throat. The most common comorbidities in IAV positive cases were hepatitis C (4%), obesity (4%) and tuberculosis (6%). The highest incidence of patients reporting to the hospital was seen three days post symptoms onset (66/311) with 14 of these (14/66) positive for IAV.

Conclusion

Distinct trends of ILI, SARI and IAV positive cases were observed which can be used to inform public health interventions (vaccinations, hand and respiratory hygiene) at appropriate times among high-risk groups. We suggest sampling from both ILI and SARI patients in routine surveillance as recommended by WHO.

Peer Review reports

Background

Influenza is a highly contagious pathogen causing a significant burden of morbidity and mortality worldwide [1]. Diverse seasonal trends across geographical regions are observed with annual epidemics and periodic pandemics caused by the emergence of novel IAVs to which humans have limited pre-existing immunity [2].

In temperate regions of the world, seasonal winter influenza epidemics increase overall morbidity and mortality and cause significant economic losses due to absenteeism from work [3, 4]. However, comparatively limited amounts of data are available concerning the burden of influenza in tropical and subtropical countries [5].

Understanding influenza seasonality and regional variation is important for developing timely preventive measures including influenza vaccination and other control strategies. In 2012, the WHO reported that 84% of countries in tropical and subtropical regions have a single peak of influenza activity which usually extends from November–December through February–March with only 4.2% having year round activity [6, 7]. Considering resource limitations, sentinel surveillance has been found superior to laboratory-based or population-based surveillance to estimate the viral determinants of ILI in developing countries.

According to World Bank, Pakistan is a lower-middle-income country (https://data.worldbank.org/country/pakistan) with a population of ~ 220 million [8] and a weak healthcare delivery system [9]. The per capita annual household income in Pakistan was US$650.64 in 2016. The climate of the country is tropical to temperate with scattered arid areas in the southern regions [10]. Influenza viruses have always been considered a significant threat to global public health [11]. Since 2009 A (H1N1pdm09), seasonal influenza (H3N2) and influenza B viruses have circulated in humans [12]. Limited data are available for circulation patterns of these viruses in Pakistan although epidemiological and clinical factors associated with H1N1pdm09 infection during the 2009–2010 pandemic [13, 14] and zoonotic influenza [15,16,17] have been reported. A recent study reported the positivity rate, seasonality, and epidemiological and clinical characteristics of ILI and SARI patients at eight sentinel sites in Pakistan during 2008–2017 [18]. In current study, one sentinel site in Lahore, which is the second most populous city of Pakistan with a population > 11 million, was included [19].

In the current study we focused on a major tertiary-care hospital in Lahore with high patient loads as the sentinel site to enroll patients using syndromic definitions for respiratory infections. We sought to describe the proportions, temporal and spatial distribution, and demographic and clinical characteristics of IAV positive ILI and SARI cases and to estimate the proportion of seasonal H3N2 and H1N1pdm09 subtypes among positive IAV cases.

Methods

Study site

Lahore is the capital city of the Punjab province of Pakistan (31°32′59″N 74°20′37″E) with a population of 11,119,985 [19]. The district is bounded on the north and west by the Sheikhupura District, on the south by the Kasur District and on the east by the Indian border (Fig. 1). Lahore has a semi-arid climate and experiences four distinct seasons i.e. summer, winter, autumn and spring [20] with June being the hottest month and January the coolest characterized by intense fog and smog, especially over the past 2–3 years [21].

Fig. 1
figure 1

Sentinel site (LGH) in Lahore District

The Lahore General Hospital (LGH) is a major public sector hospital and referral center for the population of Lahore as well as neighboring districts and includes emergency and outpatient clinics and is affiliated with Post Graduate Medical Institute (PGMI) Lahore. The capacity of LGH is 1600 beds. Approximately 14,00,000 outpatients visit various outdoor clinics of the hospital e.g. Medical unit I, II, III, Pediatrics, Neurology, Hepatic, Urology, Orthopedic, ENT, Gynecology etc. annually while the number of outpatient visits is 4000–4500 daily. The number of patients visiting emergency department is 2500–3000 daily. The hospital has 14 ventilators, 10 ICU beds, and 20 isolation beds (https://lgh.punjab.gov.pk/clinical_services).

Study population

We prospectively enrolled outpatients with influenza like illness (ILI) and inpatients with severe acute respiratory infection (SARI) according to WHO definition (see below) from those visiting a designated seasonal influenza desk for symptom screening (located within the LGH outpatient department) from Monday to Saturday during official working hours from October 2015 to May 2016. Due to logistic and access issues, we selected one sentinel hospital site from 14 Tertiary Care hospitals and sampled 5–6 patients visiting the hospital on each day, who fulfilled the ILI and/or SARI definitions. These 5–6 patients were selected conveniently from those patients, who visited the hospital in the early hours. Eligible patients were provided with an explanation of the study rationale and sample collection procedures and invited to participate voluntarily. The Independent Ethics Committee (IEC) Bioequivalence Study (Be St) Center, University of Veterinary and Animal Sciences, Lahore (Letter no. IEC-438) approved study protocol.

The standardized and January 2014-revised WHO ILI and SARI case definitions were used. A case of ILI was defined as an outpatient with history of fever (measured temperature ≥ 38 °C) during the past 10 days, and cough without the need of hospitalization. The SARI cases were defined as patients with an acute respiratory illness with onset during the previous 10 days requiring at least an overnight hospitalization and having history of fever or measured temperature of ≥ 38 °C, and cough [22]. Those who did not fulfill the case definition criteria or refused to participate were excluded from the study.

The geographical locations (street addresses) of enrolled patients were located on Google maps. A dot map of distribution of positive and negative cases of influenza A was produced using QGIS software version 3.2 (Open Source Geospatial Foundation Project, Boston, MA, USA, available at http://qgis.osgeo.org).

Data collection

Using a pretested questionnaire (Additional file 1), epidemiological data about socio-demographics, co-morbidities, exposure status, vaccination, and travel history was gathered from enrolled patients in a face-to-face interview in the local language. A unique coded identification number was given to each questionnaire and specimen tube from the same patients to keep the data confidential.

Sample collection and laboratory analysis

A registered clinical officer collected nasopharyngeal or oropharyngeal swabs from willing participants [23]. The specimen was immediately transferred into a cryovial tube containing 2-3 ml of viral transport medium. All collected specimens were transported at 4 °C to the Disease Surveillance Laboratory, Department of Epidemiology & Public Health, University of Veterinary and Animal Sciences, Lahore, Pakistan. On arrival in the laboratory, all specimens were divided into small aliquots in a biosafety level-II cabinet (BSL-2) and were stored at or below − 70 °C before shipment to the WHO Collaborating Center for Studies on the Ecology of Influenza, St. Jude Children's Research Hospital, Memphis, Tennessee, USA for influenza testing [23, 24] by using real-time RT-PCR (rRT-PCR) protocol as described by the US Centers for Disease Control and Prevention [25] for IAV. Positive IAV specimens were further subtyped for seasonal H3N2 and H1N1pdm09 by rRT-PCR using specific primers, probes [26].

Statistical analysis

Questionnaire data were entered into Epidata version 3.1 (available at http://www.epidata.dk) and validated for errors and inconsistencies. We used R software version 3.2.3 [27] for analysis of socio-demographic and clinical characteristics. Graphs were generated to present spatio-temporal trends of IAV and subtypes (seasonal H3N2 and H1N1pdm09). The denominator for calculation of various proportions was the total number of cases (all diseased) who visited the hospital during study period (n = 513,126) and total number of ILI and SARI patient enrolled in study (n = 311).

Results

Characteristics of ILI and SARI cases

From October 2015 to May 2016, a total of 513,126 patients reported to the LGH surveillance desk designated for infectious diseases. A total of 4568 patients visited the designated seasonal influenza desk with ILI or SARI symptoms. Of the 4568 patients, 311 were invited to participate and were enrolled in study. Among 311, 284 were ILI (91.3%) and 27 were SARI (8.7%) patients. The mean age among all enrolled patients was 29.20 years (median 27 years; range: 0.33–80 years). Most ILI (70.1%, mean = 29 years) and SARI patients (66.67%, mean = 29 years) were under the age of 30 years. The majority of cases were females (n = 202, 65%). Among these 202, 184 were ILI patients and 18 were SARI cases. Out of these 202 females, 140 were married and among these, 91.4% (128/140) were ILI patients and 8.6% (12/140) were SARI patients. Among married ILI female patients (n = 128), 3 (2.3%) were in first trimester of pregnancy, and 4 (3.1%) were in second trimester of pregnancy; none were in the third trimester. About 94.5% (n = 121) female ILI patients were married but not pregnant. Among married SARI female patients (n = 12), 1 (8.3%) was in the second trimester and 1 (8.3%) was in the third trimester. The number of ILI and SARI patients was higher among housewife’s compared to other occupations. In overall, a single-family system was more common (187/311: 60.1%) and families had an average monthly income of US$172. No deaths were recorded among enrolled cases. About 31.5% of patients (98/311) reported that they self-medicated with antibiotics (available over the counter in Pakistan). Among ILI patients, 27% reported self-medication with antibiotics and among SARI, 29.6% reported use of antibiotics. No patient reported the use of any antiviral drug. Out of 311 patients, 99.4% (n = 304) were unaware of the availability of any influenza vaccine. Only two patients (0.6%) knew about the seasonal influenza vaccine and one (0.3%) was vaccinated against influenza and they were among ILI cases. Among ILI patients, 16 (5.6%) were vaccinated with pneumococcal vaccine, while in SARI cases, one (3.7%) was vaccinated with pneumococcal vaccine. Majority of ILI (80.9%) and SARI (88.8%) had no travel history. Similarly, majority of ILI (87.6%) and SARI (88.8%) reported no contact with poultry. Most of the ILI (94.3%) and SARI (92.5%) did not used public transport (Tables 1 and 2).

Table 1 Distribution of various exposure characteristics among IAV positive ILI patients
Table 2 Distribution of various exposure characteristics among IAV positive SARI patients

Demographic characteristics of IAV positive cases

Among all enrolled individuals, 16% (50/311) were positive for IAV. Of these, 80% (n = 40) were from ILI and 20% (n = 10) were from SARI groups (Fig. 2). Among ILI cases, 14% (40/284) were IAV positive while among SARI cases 27% (10/27) were IAV positive.

Fig. 2
figure 2

Distribution of positive IAV cases among ILI and SARI patients by age and gender

Temporal patterns of respiratory illnesses and Influenza A

The proportion of respiratory illnesses (n = 4568) among all patients visiting the sentinel hospital during study period (n = 5,13,126) was 0.9% (95% Confidence Interval [CI]: 0.86–0.92). The proportion of enrolled ILI (284/311) was 91% (95% CI: 87.62–94.20) and enrolled SARI (27/311) was 8.68% (95% CI: 5.79–12.38). The maximum monthly number of ILI (20%) and SARI (26%) patients was seen in February (Fig. 3).

Fig. 3
figure 3

Temporal trend of ILI and SARI cases visiting sentinel hospital during October 2015 to May 2016 in Lahore, Pakistan

The proportion of IAV positive among all enrolled was 16% (50/311; 95% CI: 12.17–20.64). Among the 50 IAV positive cases, virus subtyping detected 14 (28%) as H1N1pdm09 and 15 (30%) as seasonal H3N2; the remaining 21 (42%) were untyped (Fig. 4). The detection of IAV was limited to winter months (December–February). The highest proportion (42%) of positive IAV cases was recorded during December 2015. (Fig. 4).

Fig. 4
figure 4

Number and percentage positivity of influenza-positive samples by duration of study (weeks, month) in Lahore, Pakistan

Among the ILI and SARI cases, 22.5% and 50% were H1N1pdm09 positive, 32.5% and 20% were seasonal H3N2 positive and 45% and 30% were untyped IAV positive respectively.

Characteristics of IAV positive ILI cases

Among ILI patients, the number of IAV positives was highest among the 16–30 years (55%, 22/40). Among IAV positive ILI cases, 55% were male and 45% were female. No pregnant ILI females (n = 7) were IAV positive (Table 1).

Characteristics of IAV positive SARI cases

Among SARI cases, the number of IAV positives was highest in 16–30 age group (70%, 7/10). Among IAV positive SARI cases 70% were female and 30% were male (Table 2). Both SARI pregnant females were IAV positive.

Clinical characteristics and co-morbidities

Ongoing or history of fever was the most common symptom reported in the ILI (91%) and SARI (96%) groups. Cough (85%) and Sore throat (78.5%) were the other common clinical symptoms reported by ILI cases. Cough (89%), sore throat (67%), running nose (74%), headache (74%) and muscle pain (74%) were frequently reported symptoms by SARI cases (Fig. 5, Table 3).

Fig. 5
figure 5

Distribution of clinical symptoms in ILI and SARI and IAV positive cases

Table 3 Distribution of influenza like illness (ILI) and severe acute respiratory illness (SARI) according to clinical symptoms of influenza and comorbidities during hospital based active surveillance

The most common ILI co-morbidities were hepatitis C (5.2%), tuberculosis (4.2%) and diabetes (4.2%), while the most common co-morbidities in SARI cases were diabetes (7.4%), hepatitis C (7.4%) and obesity (7.4%). In all IAV positive cases, the most common comorbidities were hepatitis C (4%), obesity (4%) and tuberculosis (6%) (Table 3).

The majority of the patients reported to the hospital on day three post symptoms onset (66/311) (interquartile range [IQR] = 2–6 days) with 14 of these IAV positive (14/66).

Spatial trend of cases

About 93.2% of the reported cases of ILI and SARI (290/311) lived in the Lahore district (Fig. 6); the remaining 21 were from other districts of Punjab province. Among the cases from Lahore district, 265 were ILI patients and 25 were SARI patients. Among IAV positive cases (n = 50), 47 were reported from Lahore district (94%).

Fig. 6
figure 6

Spatial distribution of IAV cases during sentinel surveillance from Oct 2015 to May 2016

Discussion

In our study ILI and SARI cases reported to the sentinel site throughout the study period (October 2015–May 2016), however, a peak was seen in February 2016. Influenza virus was detected in our population during the wither months (December–February) with a distinct peak in December. Extended longitudinal studies are required to determine the reproducibility of this pattern and to identify interseasonal variations. Nevertheless, this temporal trend aligns with those presented in other studies from Pakistan [18, 28] and from other countries in temperate regions like the USA and China [29,30,31,32], suggesting similar impacts of the various factors that drive influenza seasonality including climate, host, and virus characteristics [32, 33]. In current study, influenza virus was not detected in samples from ILI & SARI patients, collected in week 46 and 47 (peak season for influenza), which might be attributed to small sample size (5–6 patients per day). Other respiratory viruses e.g. metapneumovirus, parainfluenza, respiratory syncytial virus, adeno and rhinovirus could be the etiology of ILI and SARI during those weeks [34, 35]. The overall proportion of IAV positive samples was 16% among enrolled patients, which is slightly lower than that previously reported (20%) in Pakistan [18] but within the range observed elsewhere (10–50%) [13, 31, 36]. The proportion of IAV among SARI cases was substantially higher than among ILI cases, a finding consistent with conclusions that SARI-based surveillance is a good data source for estimating influenza trends [31, 37]. Among the 50 IAV positive cases, 14 were subtyped as H1N1pdm09. H1N1pdm09 was the predominant IAV subtype circulating globally in the post-pandemic period (2011–2013), including in Pakistan [14, 33, 38]. The World Health Organization stated in 2010 that the pandemic virus will continue to circulate with seasonal viruses, causing occasional outbreaks [39] which it has [40, 41]. However, with the emergence of COVID-19 pandemic in December 2019, the circulation of influenza virus has dropped to historically low levels. One plausible reason for the low level of influenza virus circulation is the non-pharmaceutical interventions implemented for COVID-19 control; notably mask wearing and social distancing as the route of transmission of IAV and SARS-CoV-2 are similar i.e. aerosol [42].

Influenza viruses can infect individuals of all ages and the epidemiology of the resulting disease can be influenced by age groups [4, 24, 33, 36, 43, 44]. In our study, young adults (16–30 years) were found to have the highest percentage of IAV positivity among ILI (55%) and SARI (70%) patients. Previous influenza surveillance in Pakistan reported that individuals between 21–40 years and 41–60 years old, were most affected during the pre-pandemic, pandemic, and post-pandemic periods [45]. In other studies, relatively high proportions of IAV cases were seen among children aged 5–17 years [24, 43, 46]. In our study, the data about age of participants was not normally distributed, which might have influenced the analysis. In developing countries like Pakistan, young people (age 16–30 years) have the easiest access to healthcare facilities, while children and older people are dependent on young family member to take them. Contrary to our results, age disparity has been reported between ILI and SARI cases and influenza positivity in various studies [43, 47]. In addition to influenza viruses, other respiratory pathogens, e.g., parainfluenza viruses and respiratory syncytial virus contribute to respiratory illness in children and the elderly [48]. In the current study, the proportion of IAV positive cases was higher among male ILI patients (55%) than female ILI cases (45%), while in SARI patients, the proportion of IAV positive cases was higher among female (70%) than male (30%). Males and females have been shown to have variation in susceptibility to influenza infection, which might be partially explained by the fact that sex-specific endocrines can affect immune responses [49, 50]. Further studies are needed to collect scientific evidence on the combined effects of age and sex as biological variables influencing IAV infection and resulting disease severity.

In our study 99.4% of participants did not know about seasonal influenza vaccine and only one participant was vaccinated with seasonal influenza vaccine. The World Health Organization highly recommends influenza vaccination on a yearly basis, especially for children and the elderly people [51]. Various factors drive low uptake in Pakistan including the relatively high cost, customs and cultural practices and low literacy rates [52].

We also analyzed the clinical characteristics of ILI, SARI and IAV positive cases. Almost all ILI and SARI (> 90%) and IAV positive cases (98%) presented with ongoing or history of fever. The second most common symptom reported by ILI, SARI and IAV positive cases was cough. A similar study conducted in Europe reported fever, malaise and cough as the most common symptoms of influenza [38]. Many other studies have suggested that influenza could be maximally predicted in patients presenting with clinical symptoms of fever and cough [13, 53,54,55,56]. Our results endorse the revised influenza case definition by WHO published in 2011 and suggest fever and cough as the main clinical predictors for influenza among ILI and SARI cases [57].

We found that hepatitis C, tuberculosis, and obesity were the most common co-morbidities in IAV positive cases. Influenza infection causes hepatic decompensation in patient with chronic liver disease and may cause hepatitis itself by stimulating liver-damaging toxic metabolites and pro-inflammatory cytokines [58]. Similarly, obesity can be thought of as a form of immunosuppression resulting in more severe pathogenesis following infection [59]. Consistent with our findings, tuberculosis has been previously identified as a risk factor for mortality in IAV patients [60].

Most of the patients in our study arrived at the hospital within three days of onset of their symptoms, a timepoint when we also had maximum detection of IAV. Detection of IAV is more likely if samples are taken within 7 days of infection [61]. Systemic symptoms such as myalgia, headache, and fever are due to cytokine release from immune cells and appear rapidly after viral infection is detected by the immune system. Symptoms of rhinorrhea and nasal congestion are produced by inflammatory mediators (prostaglandins and bradykinin) and are slower to develop but longer lasting. Accurate symptomatic diagnosis of pandemic virus infections including influenza and coronavirus is essential for the initiation of public health interventions in the community but is an area that require much research [62]. However, relying on clinical diagnosis of influenza alone will not be sufficient, as symptoms caused by other pathogens can overlap considerably and diagnostic testing must be used to aid clinical judgment and help guide treatment decisions and vaccine development [63].

The major limitations of our study were that all age groups were not equally represented in the study population. Due to logistic and access issues, we only sampled 5–6 patients on each day which might have introduced selection bias in our findings towards severely ill patients or those that lived closer to the hospital and arrived earlier. Hence, our results are probably an underestimation of the proportion of people with ILI or SARI and the proportion of those that are IAV positive. Another limitation is that we only analyzed samples for IAV and these data may not be directly generalizable to influenza B viruses. One sentinel hospital was included for data collection for a period of only 8 months, a factor that also limit the confidence in our representative estimates. Similarly, our surveillance included a small number of pregnant women (n = 9) and children (n = 41), who attended outpatient clinics, and our data on these groups may not reflect the population in pediatric or obstetric wards. As our surveillance was hospital-based, the denominator of our catchment area’s population was unavailable, therefore, cumulative incidence of influenza could not be estimated.

Conclusions

In the current study, we conclude that ILI, SARI and IAV positive cases have distinct characteristics and temporal trends. These trends may prove useful to health policy makers to initiate public health interventions at appropriate times among high-risk groups. We highly recommend inclusion of sampling from both ILI and SARI patients in routine surveillance as suggested by WHO. Influenza vaccination should be included in the expanded program on immunization (EPI) of Pakistan, which aims to decrease childhood morbidity and mortality due to vaccine preventable diseases.

Availability of data and materials

The data gathered and generated during the current study are available from the corresponding author (Mamoona Chaudhry) on reasonable request.

Abbreviations

ILI:

Influenza like illness

SARI:

Severe acute respiratory syndrome

IAV:

Influenza A virus

IQR:

Interquartile range

LGH:

Lahore General Hospital

rRT-PCR:

Real-time reverse transcriptase polymerase chain reaction

References

  1. 1.

    Lambert LC, Fauci AS. Influenza vaccines for the future. N Engl J Med. 2010;363(21):2036–44.

    CAS  PubMed  Google Scholar 

  2. 2.

    Korsun N, Angelova S, Teodosieva A. Virological surveillance of influenza in four recent post-pandemic seasons (2010/11 to 2013/14) in Bulgaria. Cent Eur J Public Health. 2016;24(3):180.

    PubMed  Google Scholar 

  3. 3.

    Molinari N-AM, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25(27):5086–96.

    PubMed  Google Scholar 

  4. 4.

    Simmerman JM, Chittaganpitch M, Levy J, Chantra S, Maloney S, Uyeki T, Areerat P, Thamthitiwat S, Olsen SJ, Fry A, et al. Incidence, seasonality and mortality associated with influenza pneumonia in Thailand: 2005–2008. PLoS ONE. 2009;4(11): e7776.

    PubMed  PubMed Central  Google Scholar 

  5. 5.

    Viboud C, Alonso WJ, Simonsen L. Influenza in tropical regions. PLOS Med. 2006;3(4): e89.

    PubMed  PubMed Central  Google Scholar 

  6. 6.

    Tamerius J, Nelson MI, Zhou SZ, Viboud C, Miller MA, Alonso WJ. Global influenza seasonality: reconciling patterns across temperate and tropical regions. Environ Health Perspect. 2010;119(4):439–45.

    PubMed  PubMed Central  Google Scholar 

  7. 7.

    Newman LP, Bhat N, Fleming JA, Neuzil KM. Global influenza seasonality to inform country-level vaccine programs: an analysis of WHO FluNet influenza surveillance data between 2011 and 2016. PLoS ONE. 2018;13(2): e0193263.

    PubMed  PubMed Central  Google Scholar 

  8. 8.

    UNO: World Population Prospects. In.; 2017.

  9. 9.

    Pakistan: Health Service Delivery. 2017. http://www.emro.who.int/pak/programmes/service-delivery.html.

  10. 10.

    Climate-Pakistan. 2020. https://www.climatestotravel.com/climate/pakistan.

  11. 11.

    Shao W, Li X, Goraya MU, Wang S, Chen J-L. Evolution of influenza a virus by mutation and re-assortment. Int J Mol Sci. 2017;18(8):1650.

    PubMed Central  Google Scholar 

  12. 12.

    Kyaw Win SM, Saito R, Win NC, Lasham DJ, Kyaw Y, Lin N, Thein KN, Chon I, Odagiri T, Thein W, et al. Epidemic of influenza A(H1N1)pdm09 analyzed by full genome sequences and the first case of oseltamivir-resistant strain in Myanmar 2017. PLoS ONE. 2020;15(3): e0229601.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. 13.

    Nisar N, Aamir UB, Badar N, Mehmood MR, Alam MM, Kazi BM, Zaidi SSZ. Prediction of clinical factors associated with pandemic influenza A (H1N1) 2009 in Pakistan. PLoS ONE. 2014;9(2): e89178.

    PubMed  PubMed Central  Google Scholar 

  14. 14.

    Bashir Aamir U, Badar N, Mehmood MR, Nisar N, Suleman RM, Shaukat S, Sharif S, Kamran J, Zaidi SSZ, Kazi BM, et al. Molecular epidemiology of influenza A(H1N1)pdm09 viruses from Pakistan in 2009–2010. PLoS ONE. 2012;7(8): e41866.

    PubMed  PubMed Central  Google Scholar 

  15. 15.

    Chaudhry M, Webby R, Swayne D, Rashid HB, DeBeauchamp J, Killmaster L, Criado MF, Lee D-H, Webb A, Yousaf S, et al. Avian influenza at animal-human interface: One-health challenge in live poultry retail stalls of Chakwal, Pakistan. Influenza Other Respir Viruses. 2020;14(3):257–65.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. 16.

    Chaudhry M, Angot A, Rashid HB, Cattoli G, Hussain M, Trovò G, Drago A, Valastro V, Thrusfield M, Welburn S, et al. Reassortant avian influenza A(H9N2) viruses in chickens in retail poultry shops, Pakistan, 2009–2010. Emerg Infect Dis. 2015;21(4):673–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. 17.

    Ahad A, Thornton RN, Rabbani M, Yaqub T, Younus M, Muhammad K, Mahmood A, Shabbir MZ, Kashem MA, Islam MZ, et al. Risk factors for H7 and H9 infection in commercial poultry farm workers in provinces within Pakistan. Prev Vet Med. 2014;117(3):610–4.

    PubMed  Google Scholar 

  18. 18.

    Nisar N, Aamir UB, Badar N, Mahmood MR, Yaqoob A, Tripathy JP, Laxmeshwar C, Tenzin K, Zaidi SSZ, Salman M, et al. Epidemiology of Influenza among patients with influenza-like illness and severe acute respiratory illness in Pakistan: a 10-year surveillance study 2008–17. J Med Virol. 2020. https://doi.org/10.1002/jmv.25913.

    Article  PubMed  Google Scholar 

  19. 19.

    Anonymous: Area, population by sex, sex ratio, population density, urban proportion, household size and annual growth rate. In. Islamabad: Pakistan Bureau of Statistics, Government of Pakistan; 2017.

  20. 20.

    Sarfaraz S, Arsalan MH, Fatima H. Regionalizing the climate of Pakistan using Köppen classification system. Pak Geogr Rev. 2014;69:111–32.

    Google Scholar 

  21. 21.

    Sajjad SH, Batool R, Qadri ST, Shirazi SA, Shakrullah K. The long-term variability in minimum and maximum temperature trends and heat island of Lahore city, Pakistan. Sci Int. 2015;27(2):1321–5.

    Google Scholar 

  22. 22.

    World Health Organization. WHO surveillance case definitions for ILI and SARI. 2014. https://www.who.int/teams/global-influenza-programme/surveillance-and-monitoring/case-definitions-for-ili-and-sari.

  23. 23.

    World Health Organization. WHO guidelines for the collection of human specimens for laboratory diagnosis of avian influenza infection. https://www.who.int/influenza/human...laboratories.../guidelines_collection...humans/e....

  24. 24.

    Zaman RU, Alamgir A, Rahman M, Azziz-Baumgartner E, Gurley ES, Sharker MAY, Brooks WA, Azim T, Fry AM, Lindstrom S. Influenza in outpatient ILI case-patients in national hospital-based surveillance, Bangladesh, 2007–2008. PLoS ONE. 2009;4(12): e8452.

    PubMed  PubMed Central  Google Scholar 

  25. 25.

    Center for Disease Control and Prevention. CDC real time RTPCR (rRTPCR) protocol for detection and chatacterization of swine influenza (version 2009). www.who.int.

  26. 26.

    Shu B, Wu K-H, Emery S, Villanueva J, Johnson R, Guthrie E, Berman L, Warnes C, Barnes N, Klimov A. Design and performance of the CDC real-time reverse transcriptase PCR swine flu panel for detection of 2009 A (H1N1) pandemic influenza virus. J Clin Microbiol. 2011;49(7):2614–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. 27.

    Team RDC: a language and environment for statistical computing. In., 3.2.3 edn. Vienna, Austria: R Foundation for Statistical Computing; 2015.

  28. 28.

    Nisar N, Badar N, Aamir UB, Yaqoob A, Tripathy JP, Laxmeshwar C, Munir F, Zaidi SSZ. Seasonality of influenza and its association with meteorological parameters in two cities of Pakistan: a time series analysis. PLoS ONE. 2019;14(7):e0219376–e0219376.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. 29.

    Yu H, Huang J, Huai Y, Guan X, Klena J, Liu S, Peng Y, Yang H, Luo J, Zheng J, et al. The substantial hospitalization burden of influenza in central China: surveillance for severe, acute respiratory infection, and influenza viruses, 2010–2012. Influenza Other Respir Viruses. 2014;8(1):53–65.

    PubMed  Google Scholar 

  30. 30.

    Peng Z, Feng L, Carolyn GM, Wang K, Zhu G, Zhang Y, Hu J, Huang Y, Pan H, Guo N, et al. Characterizing the epidemiology, virology, and clinical features of influenza in China’s first severe acute respiratory infection sentinel surveillance system, February 2011–October 2013. BMC Infect Dis. 2015;15(1):143.

    PubMed  PubMed Central  Google Scholar 

  31. 31.

    Tadesse M, Mengesha M, Tayachew A, Belay D, Hassen A, Woyessa AB, Zemelak E, Beyene B, Kassa W, Ayele W, et al. Burden and seasonality of medically attended influenza like illness (ILI) in Ethiopia, 2012 to 2017. BMC Infect Dis. 2020;20(1):148.

    PubMed  PubMed Central  Google Scholar 

  32. 32.

    Lowen AC, Steel J. Roles of humidity and temperature in shaping influenza seasonality. J Virol. 2014;88(14):7692.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. 33.

    Qi L, Xiong Y, Xiao B, Tang W, Ling H, Long J, Xiao D, Zhao H, Ye S, Chen S, et al. Epidemiological and virological characteristics of influenza in Chongqing, China, 2011–2015. PLoS ONE. 2016;11(12): e0167866.

    PubMed  PubMed Central  Google Scholar 

  34. 34.

    Stellrecht KA. Chapter 11—molecular testing for respiratory viruses. In: Coleman WB, Tsongalis GJ, editors. Diagnostic molecular pathology. Academic Press: Cambridge; 2017. p. 123–37.

    Google Scholar 

  35. 35.

    Broor S, Parveen S, Bharaj P, Prasad VS, Srinivasulu KN, Sumanth KM, Kapoor SK, Fowler K, Sullender WM. A prospective three-year cohort study of the epidemiology and virology of acute respiratory infections of children in rural India. PLoS ONE. 2007;2(6):e491–e491.

    PubMed  PubMed Central  Google Scholar 

  36. 36.

    Comach G, Teneza-Mora N, Kochel TJ, Espino C, Sierra G, Camacho DE, Laguna-Torres VA, Garcia J, Chauca G, Gamero ME, et al. Sentinel surveillance of influenza-like illness in two hospitals in Maracay, Venezuela: 2006–2010. PLoS ONE. 2012;7(9): e44511.

    CAS  PubMed  PubMed Central  Google Scholar 

  37. 37.

    Lafond KE, Nair H, Rasooly MH, Valente F, Booy R, Rahman M, Kitsutani P, Yu H, Guzman G, Coulibaly D, et al. Global role and burden of influenza in pediatric respiratory hospitalizations, 1982–2012: a systematic analysis. PLOS Med. 2016;13(3): e1001977.

    PubMed  PubMed Central  Google Scholar 

  38. 38.

    Pițigoi D, Streinu-Cercel A, Ivanciuc AE, Lazãr M, Cherciu CM, Mihai ME, Nițescu M, Aramă V, Crăciun MD, Streinu-Cercel A, et al. Surveillance of medically-attended influenza in elderly patients from Romania-data from three consecutive influenza seasons (2015/16, 2016/17, and 2017/18). Influenza Other Respir Viruses. 2020;14(5):530–40.

    PubMed  PubMed Central  Google Scholar 

  39. 39.

    H1N1 in post-pandemic period. 2010. https://www.who.int/mediacentre/news/statements/2010/h1n1_vpc_20100810/en/.

  40. 40.

    Summary of progress since 2009. 2019. https://www.cdc.gov/flu/pandemic-resources/h1n1-summary.htm.

  41. 41.

    Baldo V, Bertoncello C, Cocchio S, Fonzo M, Pillon P, Buja A, Baldovin T. The new pandemic influenza A/(H1N1)pdm09 virus: is it really “new”? J Prev Med Hyg. 2016;57(1):E19–22.

    CAS  PubMed  PubMed Central  Google Scholar 

  42. 42.

    Rubin R. Influenza’s unprecedented low profile during COVID-19 pandemic leaves experts wondering what this flu season has in store. JAMA. 2021;326(10):899–900.

    CAS  PubMed  Google Scholar 

  43. 43.

    Lutwama JJ, Bakamutumaho B, Kayiwa JT, Chiiza R, Namagambo B, Katz MA, Geissler AL. Clinic- and hospital-based sentinel influenza surveillance, Uganda 2007–2010. J Infect Dis. 2012;206(suppl_1):S87–93.

    CAS  PubMed  Google Scholar 

  44. 44.

    Drăgănescu A, Săndulescu O, Florea D, Vlaicu O, Streinu-Cercel A, Oţelea D, Aramă V, Luminos ML, Streinu-Cercel A, Niţescu M, et al. The influenza season 2016/17 in Bucharest, Romania—surveillance data and clinical characteristics of patients with influenza-like illness admitted to a tertiary infectious diseases hospital. Braz J Infect Dis. 2018;22(5):377–86.

    PubMed  Google Scholar 

  45. 45.

    Badar N, Aamir UB, Mehmood MR, Nisar N, Alam MM, Kazi BM, Zaidi SSZ. Influenza virus surveillance in Pakistan during 2008–2011. PLoS ONE. 2013;8(11): e79959.

    CAS  PubMed  PubMed Central  Google Scholar 

  46. 46.

    Worby CJ, Chaves SS, Wallinga J, Lipsitch M, Finelli L, Goldstein E. On the relative role of different age groups in influenza epidemics. Epidemics. 2015;13:10–6.

    PubMed  PubMed Central  Google Scholar 

  47. 47.

    Maïnassara HB, Lagare A, Tempia S, Sidiki A, Issaka B, Sidikou BA, Oukem-Boyer OOM. Influenza sentinel surveillance among patients with influenza-like-illness and severe acute respiratory illness within the framework of the National Reference Laboratory, Niger, 2009–2013. PLoS ONE. 2015;10(7): e0133178.

    PubMed  PubMed Central  Google Scholar 

  48. 48.

    Beauté J, Zucs P, Korsun N, Bragstad K, Enouf V, Kossyvakis A, Griškevičius A, Olinger C, Meijer A, Guiomar R. Age-specific differences in influenza virus type and subtype distribution in the 2012/2013 season in 12 European countries. Epidemiol Infect. 2015;143(14):2950–8.

    PubMed  Google Scholar 

  49. 49.

    Wong KC, Luscombe GM, Hawke C. Influenza infections in Australia 2009–2015: is there a combined effect of age and sex on susceptibility to virus subtypes? BMC Infect Dis. 2019;19(1):42.

    PubMed  PubMed Central  Google Scholar 

  50. 50.

    Gabriel G, Arck PC. Sex, immunity and influenza. J Infect Dis. 2014;209(suppl_3):S93–9.

    PubMed  Google Scholar 

  51. 51.

    Vaccination. 2021. https://www.euro.who.int/en/health-topics/communicable-diseases/influenza/vaccination.

  52. 52.

    Farrukh MJ, Ming LC, Zaidi STR, Khan TM. Barriers and strategies to improve influenza vaccination in Pakistan. J Infect Public Health. 2017;10(6):881–3.

    PubMed  Google Scholar 

  53. 53.

    Casalegno J-S, Eibach D, Valette M, Enouf V, Daviaud I, Behillil S, Vabret A, Soulary JC, Benchaib M, Cohen JM, et al. Performance of influenza case definitions for influenza community surveillance: based on the French influenza surveillance network GROG, 2009–2014. Euro Surveill. 2017;22(14):30504.

    PubMed  PubMed Central  Google Scholar 

  54. 54.

    Jones AH, Ampofo W, Akuffo R, Doman B, Duplessis C, Amankwa JA, Sarpong C, Sagoe K, Agbenohevi P, Puplampu N, et al. Sentinel surveillance for influenza among severe acute respiratory infection and acute febrile illness inpatients at three hospitals in Ghana. Influenza Other Respir Viruses. 2016;10(5):367–74.

    PubMed  PubMed Central  Google Scholar 

  55. 55.

    Ohmit SE, Monto AS. Symptomatic predictors of influenza virus positivity in children during the influenza season. Clin Infect Dis. 2006;43(5):564–8.

    PubMed  Google Scholar 

  56. 56.

    Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 2000;160(21):3243–7.

    CAS  PubMed  Google Scholar 

  57. 57.

    Fitzner J, Qasmieh S, Mounts AW, Alexander B, Besselaar T, Briand S, Brown C, Clark S, Dueger E, Gross D. Revision of clinical case definitions: influenza-like illness and severe acute respiratory infection. Bull World Health Organ. 2018;96(2):122.

    PubMed  Google Scholar 

  58. 58.

    Ohfuji S, Fukushima W, Sasaki Y, Tamori A, Kurai O, Kioka K, Maeda K, Maeda A, Hirota Y. Influenza A (H1N1) pdm09 vaccine effectiveness and other characteristics associated with hospitalization in chronic liver disease patients. Liver Int. 2014;34(5):700–6.

    CAS  PubMed  Google Scholar 

  59. 59.

    Honce RR, Schultz-Cherry S. Impact of obesity on influenza A virus pathogenesis, immune response, and evolution. Front Immunol. 2019;10:1071.

    CAS  PubMed  PubMed Central  Google Scholar 

  60. 60.

    Walaza S, Tempia S, Dawood H, Variava E, Wolter N, Dreyer A, Moyes J, Von Mollendorf C, McMorrow M, Von Gottberg A, et al. The impact of influenza and tuberculosis interaction on mortality among individuals aged ≥15 years hospitalized with severe respiratory illness in South Africa, 2010–2016. Open Forum Infect Dis. 2019;6(3):020.

    Google Scholar 

  61. 61.

    Katz MA, Muthoka P, Emukule GO, Kalani R, Njuguna H, Waiboci LW, Ahmed JA, Bigogo G, Feikin DR, Njenga MK. Results from the first six years of national sentinel surveillance for influenza in Kenya, July 2007–June 2013. PLoS ONE. 2014;9(6): e98615.

    PubMed  PubMed Central  Google Scholar 

  62. 62.

    Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis. 2005;5(11):718–25.

    PubMed  PubMed Central  Google Scholar 

  63. 63.

    Influenza signs and symptoms and the role of laboratory diagnostics. 2020. https://www.cdc.gov/flu/professionals/diagnosis/labrolesprocedures.htm.

Download references

Acknowledgements

The authors would like to thank all participants and their families for providing data and samples. We would also like to thank to staff of sentinel Hospital (LGH, Lahore) for allowing study and providing access to all patients. The authors are also thankful to project staff at Department of Epidemiology and Public Health for their support.

Funding

The current study was supported by project grant from Pak-US Science and Technology cooperation Program (Grant# Pak-US/HEC/2015/11, Pakistan; US/Grant#GDL-PakUS-2015-013, USA) awarded to Mamoona Chaudhry (Pakistan) and Richard J. Webby (USA). The funder had no role in study design, data collection/analysis/interpretation or manuscript preparation.

Author information

Affiliations

Authors

Contributions

Conceived and designed the study: MC, SH, RJW. Collected data: SH, MI. Analysis of data: SH, MC, JB; Funding acquisition: MC, RJW. Supervision: MC, MUA, JN. drafted paper: SH, MC, HBR, SS, MUA, JN. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Mamoona Chaudhry.

Ethics declarations

Ethics approval and consent to participate

The study was reviewed and approved by the Independent Ethics Committee (IEC) Bioequivalence Study (Be St) Center, University of Veterinary and Animal Sciences, Lahore (Letter no. IEC-438). We requested written informed consent from all study participants ≥ 18 years and a surrogate consent from parents or legal guardians for patients < 18 years. Each participant was given a consent form (in local or English language where appropriate) and were verbally briefed about research objectives and procedures. A well-trained team member registered with the Pakistan Medical and Dental Council (PMDC) collected swab samples and data from the participants. The team members were provided with formal training to collect data during the face-to-face interview. All methods were carried out in accordance with Declaration of Helsinki.

Consent for publication

Not applicable as no human identifiable images are provided in the manuscript.

Competing interests

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Questionnaire for data collection.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hasan, S., Webby, R.J., Iqbal, M. et al. Sentinel surveillance for influenza A viruses in Lahore District Pakistan in flu season 2015–2016. BMC Infect Dis 22, 38 (2022). https://doi.org/10.1186/s12879-021-07021-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12879-021-07021-7

Keywords

  • Influenza
  • Active surveillance
  • Influenza like illness (ILI)
  • Severe acute respiratory illness (SARI)
  • Pandemic
  • Seasonal influenza